XML 51 R36.htm IDEA: XBRL DOCUMENT v3.22.4
Employee Benefit Plans (Tables)
12 Months Ended
Dec. 31, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of grants of share-based awards

The following grants of share-based awards were made in 2022 under the 2005 Incentive Plan:

Grant Date

Fair Value

Date of Grant

    

Award Type

    

Shares/Units

    

Per Share/Unit

    

Vesting Period

January 1, 2022 (1)

 

RSU

 

1,065,705

$

3.12

 

33% per year over three years

January 4, 2022 (1)

 

PSU

 

1,065,705

$

4.25

 

100% on January 4, 2025

January 4, 2022 (2)

 

Restricted stock

 

15,775

$

3.12

 

100% on January 1, 2024

April 1, 2022 (2)

 

Restricted stock

 

14,710

$

4.78

 

100% on January 1, 2024

July 1, 2022 (2)

 

Restricted stock

 

14,867

$

3.10

 

100% on January 1, 2024

September 22, 2022 (3)

 

Restricted stock

 

19,328

$

4.38

 

100% on September 22, 2023

October 1, 2022 (2)

 

Restricted stock

 

12,796

$

3.86

 

100% on January 1, 2024

December 7, 2022 (2)

 

Restricted stock

 

175,882

$

5.97

 

100% on December 7, 2023

(1)Reflects grants to our executive officers.
(2)Reflects grants to certain independent members of our Board who have elected to take their quarterly fees in stock in lieu of cash, of which 8,013 shares granted on January 4, 2022 and 5,230 shares granted on April 1, 2022 vested upon the approval of our Board’s Compensation Committee in connection with the departure of an independent director during the second quarter 2022.
(3)Reflects restricted stock grants made to two new independent members of our Board in connection with their appointment to our Board.
Summary of information about restricted stock The following table summarizes information about our restricted stock:

Year Ended December 31,

2022

2021

2020

Grant Date

Grant Date

Grant Date 

    

Shares

    

 Fair Value (1)

    

Shares

    

 Fair Value (1)

    

Shares

    

Fair Value (1)

Awards outstanding at beginning of year

 

853,726

$

5.62

 

1,176,951

$

6.61

 

1,173,045

$

6.81

Granted

 

253,358

 

5.33

 

332,841

 

3.59

 

667,752

 

7.06

Vested (2)

 

(719,456)

 

4.94

 

(656,066)

 

6.35

 

(631,498)

 

7.52

Forfeited

 

 

 

 

 

(32,348)

 

5.41

Awards outstanding at end of year

 

387,628

$

6.70

 

853,726

$

5.62

 

1,176,951

$

6.61

(1)Represents the weighted average grant date fair value, which is based on the quoted closing market price of our common stock on the trading day prior to the date of grant.
(2)Total fair value of restricted stock that vested during the years ended December 31, 2022, 2021 and 2020 was $2.9 million, $2.6 million and $5.4 million, respectively.
Summary of information about PSU awards

The following table summarizes information about our PSU awards:

    

Year Ended December 31,

2022

2021

2020

Grant Date

Grant Date

Grant Date

    

Units

    

Fair Value (1)

    

Units

    

Fair Value (1)

    

Units

    

Fair Value (1)

PSU awards outstanding at beginning of year

 

1,381,469

$

8.34

 

1,297,126

$

9.99

 

1,565,044

$

10.17

Granted

 

1,065,705

 

4.25

 

452,381

 

5.33

 

369,938

 

13.15

Vested

 

(559,150)

 

7.60

 

(368,038)

 

10.44

 

(589,335)

 

12.64

Forfeited

 

 

 

 

 

(48,521)

 

7.60

PSU awards outstanding at end of year

 

1,888,024

$

6.25

 

1,381,469

$

8.34

 

1,297,126

$

9.99

(1)Represents the weighted average grant date fair value.
Summary of information about RSU awards

The following table summarizes information about our RSU awards:

    

Year Ended December 31,

2022

2021

Grant Date

Grant Date

    

Units

    

Fair Value (1)

    

Units

    

Fair Value (1)

RSU awards outstanding at beginning of year

 

452,381

$

4.20

 

$

Granted

 

1,065,705

 

3.12

 

452,381

 

4.20

Vested

 

(150,792)

 

4.20

 

 

RSU awards outstanding at end of year

 

1,367,294

$

3.36

 

452,381

$

4.20

(1)Represents the weighted average grant date fair value, which is based on the quoted closing market price of our common stock on the trading day prior to the date of grant.